State Street
IDYA icon

State Street’s IDEAYA Biosciences IDYA Stock Holding History

State Street’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$126M Sell
3,781,167
-353,474
-9% -$11.9M ﹤0.01% 1247
2025
Q4 		$143M Buy
4,134,641
+893,707
+28% +$28.5M ﹤0.01% 1148
2025
Q3 		$88.2M Sell
3,240,934
-144,860
-4% -$3.5M ﹤0.01% 1402
2025
Q2 		$71.2M Sell
3,385,794
-60,436
-2% -$1.16M ﹤0.01% 1489
2025
Q1 		$56.4M Buy
3,446,230
+125,332
+4% +$2.67M ﹤0.01% 1575
2024
Q4 		$85.3M Buy
3,320,898
+2,962
+0.1% +$83.9K ﹤0.01% 1438
2024
Q3 		$105M Buy
3,317,936
+443,640
+15% +$16.8M ﹤0.01% 1296
2024
Q2 		$101M Sell
2,874,296
-289,658
-9% -$11.5M ﹤0.01% 1252
2024
Q1 		$139M Buy
3,163,954
+172,055
+6% +$7.4M 0.01% 1103
2023
Q4 		$106M Buy
2,991,899
+844,399
+39% +$25.2M 0.01% 1254
2023
Q3 		$57.9M Buy
2,147,500
+8,997
+0.4% +$228K ﹤0.01% 1537
2023
Q2 		$50.3M Buy
2,138,503
+24,186
+1% +$497K ﹤0.01% 1673
2023
Q1 		$29M Sell
2,114,317
-208,324
-9% -$3.47M ﹤0.01% 1987
2022
Q4 		$42.2M Buy
2,322,641
+422,260
+22% +$7.1M ﹤0.01% 1755
2022
Q3 		$28.4M Buy
1,900,381
+418,227
+28% +$5.43M ﹤0.01% 1980
2022
Q2 		$20.5M Sell
1,482,154
-388,216
-21% -$4.32M ﹤0.01% 2218
2022
Q1 		$20.9M Buy
1,870,370
+177,663
+10% +$2.62M ﹤0.01% 2361
2021
Q4 		$40M Buy
1,692,707
+653,006
+63% +$15.2M ﹤0.01% 1964
2021
Q3 		$26.5M Buy
1,039,701
+658,543
+173% +$15.4M ﹤0.01% 2275
2021
Q2 		$8M Buy
381,158
+130,090
+52% +$2.67M ﹤0.01% 3025
2021
Q1 		$5.9M Buy
251,068
+21,144
+9% +$408K ﹤0.01% 2975
2020
Q4 		$3.22M Buy
229,924
+21,840
+10% +$296K ﹤0.01% 3163
2020
Q3 		$2.61M Buy
208,084
+40,058
+24% +$496K ﹤0.01% 3089
2020
Q2 		$2.39M Buy
+168,026
New +$1.32M ﹤0.01% 3111

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

State Street's IDYA Position: Q1 2026 in Review

State Street reduced its IDEAYA Biosciences (IDYA) stake by 8.5% in Q1 2026, selling an estimated $11.9M and leaving 3,781,167 shares worth $126M. The position accounts for ﹤0.01% of the portfolio, ranked #1247.

State Street first reported a position in IDYA in Q2 2020 and has held it in 24 quarters since. The position peaked at $143M in Q4 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • State Street held 3,781,167 shares of IDEAYA Biosciences worth $126M as of Q1 2026.
  • State Street sold 353,474 IDEAYA Biosciences shares in Q1 2026, an estimated $11.9M.
  • IDEAYA Biosciences made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1247 holding.
  • State Street first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 24 quarters since.
  • State Street's IDEAYA Biosciences position peaked at $143M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.